Brain Health
Gut-Brain Connection May Drive Parkinson's Disease From Digestive Tract
New research reveals how Parkinson's pathology may originate in the gut and spread to the brain via neural pathways.
Research Paper
Apr 2, 2026 0
Results for "GLP-1 Agonists" in Alzheimer's
59 articles
Metabolic Health
New Guidelines for GLP-1 Drugs During Surgery Address Safety Concerns
Expert consensus provides updated recommendations for managing popular weight-loss medications before and after surgery.
Research Paper
Apr 2, 2026 0
Longevity & Aging
Tirzepatide Shows Promise Against Semaglutide in Major Obesity Treatment Study
New research compares two leading GLP-1 medications for obesity treatment, potentially reshaping clinical practice.
Research Paper
Mar 31, 2026 0
Longevity & Aging
Aging Fat Tissue Drives Disease Risk But New Therapies Show Promise
Review reveals how adipose tissue changes with age affect metabolism and lifespan, plus potential interventions to combat aging.
Research Paper
Mar 31, 2026 0
Brain Health
How Repurposed Drugs Could Save Your Life When Standard Medicine Fails
Dr. Fajgenbaum reveals how existing medications can treat diseases they weren't designed for, potentially saving lives.
Podcast
Mar 30, 2026 0
Gut & Microbiome
Why 95% of Diets Fail and the Science-Backed Alternative That Actually Works
Nutrition experts reveal why crash diets backfire and share the flexible approach that helps people lose weight sustainably.
Video
Mar 29, 2026 0
Metabolic Health
GLP-1 Weight Loss Drugs Show Major Results But Raise Safety Questions
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
Press Release
Mar 29, 2026 12
Longevity & Aging
Microdosing GLP-1 Drugs for Longevity Shows Promise But Carries Unknown Risks
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Video
Mar 29, 2026 1
Longevity & Aging
FDA Approves GLP-1 Drugs for Fatty Liver Disease With 63% Success Rate
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
Video
Mar 29, 2026 0
Cancer Research
GLP-1 Drugs Like Ozempic May Reduce Cancer Risk Through Multiple Pathways
New research reveals how popular weight-loss medications could offer unexpected cancer protection benefits.
Research Paper
Mar 29, 2026 3
Heart Health
GLP-1 Drugs Linked to Rising Pancreatitis Deaths Prompting New Safety Warning
Health authorities issue new warnings as reports of fatal pancreatitis cases increase among GLP-1 drug users.
Research Paper
Mar 29, 2026 2
Heart Health
Diabetes Drugs Show Promise for Slowing Frailty in Older Adults
New research suggests certain diabetes medications may help older adults maintain strength and independence longer.
Research Paper
Mar 29, 2026 0
Page 1 of 5Next